Filing Details
- Accession Number:
- 0001209191-18-046554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-14 13:23:50
- Reporting Period:
- 2018-08-10
- Accepted Time:
- 2018-08-14 13:23:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1459351 | Dennis Kevin Green | C/O Cerus Corporation 2550 Stanwell Drive Concord CA 94520 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-10 | 50 | $2.48 | 60,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-10 | 50 | $6.96 | 60,825 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-08-10 | 2,733 | $2.15 | 63,558 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-10 | 2,733 | $6.96 | 60,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2018-08-10 | 50 | $0.00 | 50 | $2.48 |
Common Stock | Option (Right to Buy) | Disposition | 2018-08-10 | 2,733 | $0.00 | 2,733 | $2.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-01-02 | No | 4 | M | Direct | |
22,267 | 2019-09-30 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $6.86 to $7.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options fully vested on March 31, 2011
- Not applicable.
- One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter.